Spravato – Ketamine


Psychiatry Associates of Kansas City (PAKC) is now offering Spravato (esketamine) as a form of treatment for Major Depressive Disorder (MDD) and Treatment Resistant Depression (TRD).  Spravato (esketamine) is a nasal spray that is given in our office under the supervision of a psychiatrist and other qualified medical staff.   It is FDA approved and covered by most insurance companies.

We are here for you!

Contact our office (913-385-7252) to find out more about Spravato (esketamine) or talk to your psychiatrist at your next appointment.
freedom-from-depression-pakc-kansas city psychiatrist

Spravato® (esketamine) is a medication that is FDA approved to treat symptoms of Major depressive disorder as well as treatment resistant depression and is delivered via nasal spray. Spravato® (esketamine) works via NMDA receptor antagonism to relieve symptoms of depression. Spravato® (esketamine) is currently indicated for use in conjunction with an oral antidepressant medication.

Spravato® (esketamine) is an intranasal treatment that will require a minimum of a two-hour observation visit (longer if symptoms require further observation before a safe discharge can be achieved).  The physician will assist in administration of the Spravato® (esketamine) nasal spray.

The treating psychiatrist will determine the appropriate dosage of Spravato® (esketamine) and the dosage may vary over the course of the treatments with Spravato® (esketamine).  An appropriately trained staff member will monitor the patient and will be taking blood pressures during the monitoring process at a minimum of every forty minutes or sooner if necessary.

A course of Spravato® (esketamine) will begin as twice weekly treatments for the first four weeks of treatment. Treatment will then continue once a week for the next four weeks. Treatment frequency following the initial eight weeks of treatment will be determined by patient’s treating psychiatrist and will be based on the patient’s response to treatment.

Screening Form




Leawood, Kansas

Meredith, Clinical Director

Meredith graduated from Northwest Missouri State University with a B.S. in Psychology and attended the University of Kansas for graduate school. After years of working in residential treatment with adolescents, Meredith accepted the position of Physician Assistant at PAKC in 2010. She has since helped to launch the TMS and Ketamine programs at PAKC in 2016. She is also a certified Magstim technician.

Meredith believes in the life changing potential of TMS and is excited to help bring transformation to our patients, and see them return to a healthier life.

In her free time, she enjoys spending time with her husband and two daughters. In her free time she is interested in genealogy and loves to travel.


Leawood, Kansas

Kyla, Clinical Programs Manager

Kyla is a registered nurse with 19 years of experience helping patients. She provides exceptional patient care while advocating for each individual patient. She strives to provide an enjoyable experience for each patient during their journey to wellness.

In her free time, Kyla enjoys spending time with her husband and children. She is a lover of wiener dogs and all things Christmas.


Leawood, Kansas

Sam, Clinical Technician

Sam is a respiratory therapist with 14 years of experience in acute care hospitals and sleep medicine. She enjoys getting to know each of her patients and believes a strong patient-clinical relationship is the foundation of successful treatment.

Sam enjoys camping and road trips with her two daughters and dog.